BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Business

  Biostage Appoints Stephen F. Badylak DVM, Phd, MD, As Co-Chairman Of Scientific Advisory Board

  April 18, 2017

   · 

  6 min read
• Business

  Cardinal Health Updates Fiscal 2017 Guidance; Provides Early Outlook For Future Fiscal Years

  April 18, 2017

   · 

  7 min read
• Business

  Protea Biosciences Announces 2016 Year End Results

  April 18, 2017

   · 

  4 min read
• Drug Development

  Circassia Finally Throws In The Towel On Allergy Program After Trial Failures

  April 18, 2017

   · 

  6 min read
• Pharm Country

  Interpace Diagnostics Announces Coverage Of ThyraMIR With UnitedHealthcare

  April 18, 2017

   · 

  6 min read
• Enzyvant Sciences Receives FDA Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy Designation for Investigational Therapy RVT-802

  April 18, 2017

   · 

  4 min read
• Business

  Lombard Medical CEO Steps Down, Effective Immediately

  April 18, 2017

   · 

  1 min read
• Drug Development

  Egalet Announces FDA Acceptance Of File For Prior Approval Supplement For OXAYDO (Oxycodone Hcl, USP) Tablets C-II 10 Mg And 15 Mg Dosage Strengths

  April 18, 2017

   · 

  10 min read
• Drug Development

  BioSpecifics Technologies Corporation Initiates Phase I Clinical Trial Of XIAFLEX For Treatment Of Uterine Fibroids

  April 18, 2017

   · 

  5 min read
• Drug Development

  Abide Therapeutics Announces Dosing Of First Patient In Phase Ib Study Of ABX-1431 In Tourette Syndrome And Collaboration With Tourette Association Of America

  April 18, 2017

   · 

  4 min read